Expertise in
6
conditions

Dr. Richard G. Wunderink

Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
Accepting New Patients
Referral may be required
Before you request
Expertise in
6
conditions
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 

Overview

Richard Wunderink is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois.

Dr. Wunderink is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pneumonia, Hospital-Acquired Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Gastrostomy, and Endoscopy.

Dr. Wunderink is board certified in American Board Of Internal Medicine - Critical Care Medicine (Certified). He is actively involved in clinical research, co-authoring 277 peer reviewed articles and participating in 5 clinical trials. Dr. Wunderink is currently accepting new patients.

Graduate Institution

Indiana University School Of Medicine

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Medicine - Critical Care Medicine (Certified)

Fellowships

Henry Ford Hospital/ Wayne State University
Henry Ford Hospital/ Wayne State University

Hospital Affiliations

Northwestern Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

676 N St Clair St Ste 2100, Arkes Pavilion, Chicago, IL 60611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Part 1: A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Severe COVID-19 Pneumonia Part 2: A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)
Part 1: A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Severe COVID-19 Pneumonia Part 2: A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)
Enrollment Status: Completed
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drug: Auxora
Study Phase: Phase 2
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Enrollment Status: Active_not_recruiting
Publish Date: March 16, 2026
Intervention Type: Drug, Biological
Study Drugs: Remdesivir, Cenicriviroc, Icatibant, Pulmozyme, IC14, Celecoxib, Narsoplimab
Study Phase: Phase 2
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
A Randomized, Controlled, Open-labeled, Multi-center Clinical Trial to Evaluate the Safe and Effective Performance of the Lungpacer Diaphragm Pacing Therapy System in Patients Who Have Failed to Wean From Mechanical Ventilation.
Enrollment Status: Terminated
Publish Date: December 09, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Prospective, Biomarker-result-blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic's abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis
A Multicenter, Prospective, Biomarker-result-blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic's abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis
Enrollment Status: Completed
Publish Date: January 30, 2024
Intervention Type: Device
Rapid Diagnostic Testing to Guide Antibiotic Therapy in Drug Resistant Pneumonia
Rapid Diagnostic Testing to Guide Antibiotic Therapy in Drug Resistant Pneumonia
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Other
Study Phase: Not Applicable
View 4 Less Clinical Trials

277 Total Publications

Guideline misconceptions compromise outcome of pneumonia in immunocompromised hosts.
Guideline misconceptions compromise outcome of pneumonia in immunocompromised hosts.
Journal: Annals of the American Thoracic Society
Published: August 03, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Mary E. Strek
Pulmonary Medicine
Expertise in
21
conditions
Dr. Mary E. Strek
Pulmonary Medicine
Referral may be required

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (7.3 miles away)
888-824-0200
Languages Spoken:
English, French, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mary Strek is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois. Dr. Strek is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Strek is board certified in Internal Medicine Pulmonary Disease and Practicing Since1990. Dr. Strek is currently accepting new patients.

Expertise in
9
conditions
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine
Expertise in
9
conditions
Dr. Ayodeji O. Adegunsoye
Pulmonary Medicine
Referral may be required
Before you request

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (7.3 miles away)
888-824-0200
Languages Spoken:
English, Yoruba
See accepted insurances
Accepting New Patients
Offers Telehealth

Ayodeji Adegunsoye is a Pulmonary Medicine provider practicing medicine in Chicago, Illinois. Dr. Adegunsoye is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Hypersensitivity Pneumonitis, and Lung Transplant. Dr. Adegunsoye is board certified in Pulmonary Disease, 2017, Internal Medicine, Practicing Since, and Critical Care Medicine. Dr. Adegunsoye is currently accepting new patients.

Expertise in
4
conditions
Dr. Robert A. Cohen
Pulmonary Medicine
Expertise in
4
conditions
Dr. Robert A. Cohen
Pulmonary Medicine
Referral may be required
Before you request

Northwestern Medical Group

675 N St Clair St, Suite 18-250 Galter Pavilion, 
Chicago, IL 
 (0.5 miles away)
312-695-1800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Robert Cohen, MD is a Pulmonologist in Chicago, IL and has over 41 years of experience in the medical field. He graduated from Northwestern U, School of Medicine in 1981. Dr. Cohen is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Coal Worker's Pneumoconiosis, Interstitial Lung Disease, Acute Interstitial Pneumonia, Silicosis, and Lung Transplant. Dr. Cohen is board certified in American Board Of Internal Medicine - Internal Medicine. Dr. Cohen is currently accepting new patients.

Frequently Asked Questions about Dr. Richard G. Wunderink

How do I make an appointment with Dr. Richard G. Wunderink?

You can book an appointment with Dr. Richard G. Wunderink by calling their office at 312-695-1800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard G. Wunderink a top-rated expert for Pneumonia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard G. Wunderink is classified as an Elite expert for Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard G. Wunderink specialize in?

While Dr. Richard G. Wunderink is a Pulmonary Medicine, they have specific expertise in Pneumonia, Hospital-Acquired Pneumonia, and Acute Respiratory Distress Syndrome (ARDS). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Richard G. Wunderink participate in research or clinical trials?

Yes. Dr. Richard G. Wunderink has published 277 articles and abstracts on conditions like Pneumonia. You can view a list of Dr. Richard G. Wunderink's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard G. Wunderink accept my insurance?

Dr. Richard G. Wunderink accepts most major insurance plans, including Aetna and Humana. We recommend calling the office directly at 312-695-1800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wunderink's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile